A recent study led byDr. Erika Rosenof theAlcohol Research GroupandRTI Internationaland published in theJournal of Studies on Alcohol and Drugs, explores the differential impacts of alcohol, cannabis, and opioids on U.S. adults.

This research is significant for the cannabis industry as it highlights the relatively lower harms of cannabis compared to alcohol and opioids, presenting a strong case for cannabis-infused beverages as safer alternatives.

As consumer preferences shift towards healthier options, the cannabis beverage market stands to benefit from increased acceptance and potential regulatory ease, marking a promising growth area within...